Surgery and OncologySurgery and OncologyХирургия и онкология2949-5857Publishing House ABV Press21410.17650/2220-3478-2017-7-2-11-19ORIGINAL REPORTSОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯThe choice of optimal lymph node dissection extent in surgical treatment for colon cancer: protocol the clinical trialВыбор оптимального объема лимфодиссекции в хирургическом лечении рака ободочной кишки: протокол клинического исследованияKarachunA. M.КарачунА. М.
Russian Federation
dr.a.karachun@gmail.comPanayottiL. L.ПанайоттиЛ. Л.
Russian Federation
dr.a.karachun@gmail.comPetrovA. S.ПетровА. С.
Russian Federation
dr.a.karachun@gmail.comN.N. Petrov National Medical Research Oncology Center, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Петрова» Минздрава России280920177211192809201728092017Copyright ©; 2017, ABV-pressCopyright ©; 2017, АБВ-пресс2017ABV-pressАБВ-прессhttps://onco-surgery.info/jour/about/editorialPolicieshttps://onco-surgery.info/jour/article/view/214

Background. The choice of the best surgical approach to colon cancer treatment remains a complicated and controversial problem of modern coloproctology. Current data shows better long-term outcomes after procedures performed in accordance with embryological layers and concept of complete mesocolic excision, while level of vessel ligation remains debatable. In the US and Europe D3 lymph node dissection is not routinely performed for colon cancer, while in eastern countries it is considered to be a standard. Up-to-date there is no published data from randomized trials comparing long-term outcomes of D2 and D3 dissection. Materials and methods. A literature review was performed to evaluate current data on colon cancer lymph node dissection. A design of ran-domized trial was proposed to obtain the evidence on the superiority of D3 over D2 lymph node dissection. Discussion. As evidence regarding long-term outcomes of D3 lymph node dissection is lacking the choice of lymph node dissection is made according to surgeon’s or clinic preferences. Conclusion. To objectify the preferred lymph node dissection extent randomized controlled studies are needed.

 

 

colon cancercomplete mesocolic excisionlymph node dissection D2, D3randomized trialрак ободочной кишкитотальная мезоколонэктомиялимфодиссекция D2, D3рандомизированное исследование1. Rectum J.R. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Jpn J Surg 1983;13(6):574–98. PMID: 6672391.Rectum J.R. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Jpn J Surg 1983;13(6):574–98. PMID: 6672391.2. Watanabe T., Itabashi M., Shimada Y. et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 2015;20(2):207–39. DOI: 10.1007/s10147-015-0801-z.Watanabe T., Itabashi M., Shimada Y. et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol 2015;20(2):207–39. DOI: 10.1007/s10147-015-0801-z.3. Toyota S., Ohta H., Anazawa S. Rationale for extent of lymphnodedis section for right colon cancer. Dis Colon Rectum 1995;38(7):705–11. PMID: 7607029.Toyota S., Ohta H., Anazawa S. Rationale for extent of lymphnodedis section for right colon cancer. Dis Colon Rectum 1995;38(7):705–11. PMID: 7607029.4. Martling A.L., Holm T., Rutqvist L.E.Martling A.L., Holm T., Rutqvist L.E.et al. Effect of a surgical training programme on outcome of rectal ancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356(9224):93–6. PMID: 10963244.5. Sondenaa K., Quirke P., Hohenberger W. et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference. Int J Colorectal Dis 2014;29(4):419–28. DOI: 10.1007/s00384-013-1818-2.Sondenaa K., Quirke P., Hohenberger W. et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference. Int J Colorectal Dis 2014;29(4):419–28. DOI: 10.1007/s00384-013-1818-2.6. West N.P., Kobayashi H., Takahashi K. et al. Under standing optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 2012;30(15):1763–9. DOI: 10.1200/JCO.2011.38.3992.West N.P., Kobayashi H., Takahashi K. et al. Under standing optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol 2012;30(15):1763–9. DOI: 10.1200/JCO.2011.38.3992.7. Gouvas N., Agalianos C., Papaparaskeva K. et al. Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision. Int J Colorectal Dis 2016;31(9):1577–94. DOI: 10.1007/s00384-016-2626-2.Gouvas N., Agalianos C., Papaparaskeva K. et al. Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision. Int J Colorectal Dis 2016;31(9):1577–94. DOI: 10.1007/s00384-016-2626-2.8. Tsai H.L., Lu C.Y., Hsieh J.S. et al. The prognostic significance of total lymph node harvest in patients with T2–4N0M0 colorectal cancer. J Gastrointest Surg 2007;11(5):660–5. DOI: 10.1007/s11605-007-0119-x. PMID: 17468927.Tsai H.L., Lu C.Y., Hsieh J.S. et al. The prognostic significance of total lymph node harvest in patients with T2–4N0M0 colorectal cancer. J Gastrointest Surg 2007;11(5):660–5. DOI: 10.1007/s11605-007-0119-x. PMID: 17468927.9. Hohenberger W., Weber K., Matzel K. et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome. Colorectal Dis 2009;11(4):354–64;discussion 364–5. DOI: 10.1111/j.1463-1318.2008.01735.x.Hohenberger W., Weber K., Matzel K. et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome. Colorectal Dis 2009;11(4):354–64;discussion 364–5. DOI: 10.1111/j.1463-1318.2008.01735.x.10. Kessler H., Hohenberger W. Extended lymphadenectomy in colon cancer is crucial. World J Surg 2013;37(8):1789–98. DOI: 10.1007/s00268-013-2130-6.Kessler H., Hohenberger W. Extended lymphadenectomy in colon cancer is crucial. World J Surg 2013;37(8):1789–98. DOI: 10.1007/s00268-013-2130-6.11. West N.P., Hohenberger W., Weber K. et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010;28(2):272–8. DOI: 10.1200/JCO.2009.24.1448.West N.P., Hohenberger W., Weber K. et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010;28(2):272–8. DOI: 10.1200/JCO.2009.24.1448.12. West N.P., Morris E.J., Rotimi O. et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008;9(9):857–65. DOI: 10.1016/S1470-2045(08)70181-5.West N.P., Morris E.J., Rotimi O. et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol 2008;9(9):857–65. DOI: 10.1016/S1470-2045(08)70181-5.13. West N.P., Sutton K.M., Ingeholm P. et al. Improving the quality of colon cancer surgery through a surgical ducation program. Dis Colon Rectum 2010;53(12):1594–603. DOI: 10.1007/DCR.0b013e3181f433e3.West N.P., Sutton K.M., Ingeholm P. et al. Improving the quality of colon cancer surgery through a surgical ducation program. Dis Colon Rectum 2010;53(12):1594–603. DOI: 10.1007/DCR.0b013e3181f433e3.14. Willaert W., Ceelen W. Extent of surgery in cancer of the colon: is more better? World J Gastroenterol 2015;21(1):132–8. DOI: 10.3748/wjg.v21.i1.132.Willaert W., Ceelen W. Extent of surgery in cancer of the colon: is more better? World J Gastroenterol 2015;21(1):132–8. DOI: 10.3748/wjg.v21.i1.132.15. Willaert W., Mareel M., Van De Putte D. et al. Lymphatic spread, nodal count and the exten tof lymphadenectomy in cancer of the colon. Cancer Treat Rev 2014;40(3):405–13. DOI: 10.1016/j.ctrv.2013.09.013.Willaert W., Mareel M., Van De Putte D. et al. Lymphatic spread, nodal count and the exten tof lymphadenectomy in cancer of the colon. Cancer Treat Rev 2014;40(3):405–13. DOI: 10.1016/j.ctrv.2013.09.013.16. Liang J., Fazio V., Lavery I. et al. Primacy of surgery for colorectal cancer. Br J Surg 2015;102(7):847–52. DOI: 10.1002/bjs.9805.Liang J., Fazio V., Lavery I. et al. Primacy of surgery for colorectal cancer. Br J Surg 2015;102(7):847–52. DOI: 10.1002/bjs.9805.17. Rosenberg J., Fischer A., Haglind E. Current controversies in colorectal surgery: the way to resolve uncertainty and move forward. Colorectal Dis 2012;14(3):266–9. DOI: 10.1111/j.1463-1318.2011.02896.x.Rosenberg J., Fischer A., Haglind E. Current controversies in colorectal surgery: the way to resolve uncertainty and move forward. Colorectal Dis 2012;14(3):266–9. DOI: 10.1111/j.1463-1318.2011.02896.x.18. Bertelsen C.A., Neuenschwander A.U., Jansen J.E. et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol 2015;16(2):161–8. DOI: 10.1016/S1470-2045(14)71168-4.Bertelsen C.A., Neuenschwander A.U., Jansen J.E. et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol 2015;16(2):161–8. DOI: 10.1016/S1470-2045(14)71168-4.19. Bokey E.L., Chapuis P.H., Dent O.F. et al. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 2003;46(7):860–6. DOI: 10.1097/01.DCR.0000074731.78773.BB. PMID: 12847357.Bokey E.L., Chapuis P.H., Dent O.F. et al. Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 2003;46(7):860–6. DOI: 10.1097/01.DCR.0000074731.78773.BB. PMID: 12847357.20. Chang G.J., Rodriguez-Bigas M.A., Skibber J.M., Moyer V.A. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007;99(6):433–41. DOI: 10.1093/jnci/djk092. PMID: 17374833.Chang G.J., Rodriguez-Bigas M.A., Skibber J.M., Moyer V.A. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007;99(6):433–41. DOI: 10.1093/jnci/djk092. PMID: 17374833.21. Eiholm S., Ovesen H. Total mesocolic excision versus traditional resection in right-sided colon cancer – method and increased lymph node harvest. Dan Med Bull 2010;57(12):A4224. PMID: 21122462.Eiholm S., Ovesen H. Total mesocolic excision versus traditional resection in right-sided colon cancer – method and increased lymph node harvest. Dan Med Bull 2010;57(12):A4224. PMID: 21122462.22. Galizia G., Lieto E., DeVita F. et al. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study. Int J Colorectal Dis 2014;29(1):89–97. DOI: 10.1007/s00384-013-1766-x.Galizia G., Lieto E., DeVita F. et al. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study. Int J Colorectal Dis 2014;29(1):89–97. DOI: 10.1007/s00384-013-1766-x.23. Mukai M., Ito I., Mukoyama S. et al. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes’ B and C colorectal cancer: a 17-year retrospective study. Oncol Rep 2003;10(4):927–34. PMID: 12792747.Mukai M., Ito I., Mukoyama S. et al. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes’ B and C colorectal cancer: a 17-year retrospective study. Oncol Rep 2003;10(4):927–34. PMID: 12792747.24. Siani L.M., Pulica C. Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: Long-term oncologic outcome between mesocolic and non-mesocolic planes of surgery. Scand J Surg 2015;104(4): 219–26. DOI: 10.1177/1457496914557017.Siani L.M., Pulica C. Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: Long-term oncologic outcome between mesocolic and non-mesocolic planes of surgery. Scand J Surg 2015;104(4): 219–26. DOI: 10.1177/1457496914557017.25. Storli K.E., Sondenaa K., Furnes B. et al. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I–II. Tech Coloproctol 2014;18(6):557–64. DOI: 10.1007/s10151-013-1100-1.Storli K.E., Sondenaa K., Furnes B. et al. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I–II. Tech Coloproctol 2014;18(6):557–64. DOI: 10.1007/s10151-013-1100-1.26. Tagliacozzo S., Accordino M., Tocchi A. Extended lymphadenectomy during resection of cancer of the right colon. Eur J Surg 1994;160(3):179–81. PMID: 8003571.Tagliacozzo S., Accordino M., Tocchi A. Extended lymphadenectomy during resection of cancer of the right colon. Eur J Surg 1994;160(3):179–81. PMID: 8003571.27. Kotake K., Mizuguchi T., Moritani K. et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis 2014;29(7):847–52. DOI: 10.1007/s00384-014-1885-z.Kotake K., Mizuguchi T., Moritani K. et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Colorectal Dis 2014;29(7):847–52. DOI: 10.1007/s00384-014-1885-z.28. Feng B. Laparoscopic Complete Mesocolic Excision on Colon Cancer (LCME). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National LibraryFeng B. Laparoscopic Complete Mesocolic Excision on Colon Cancer (LCME). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Libraryof Medicine (US), 2000. Available at: https://clinicaltrials.gov/ct2/show/ NCT01628250.29. Pekin Union Medical College Hospital. Investigate the Radical ExtentPekin Union Medical College Hospital. Investigate the Radical Extentof Lymphadenectomy of Laparoscopic Right Colectomy for Colon Cancer (RELARC) In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), 2000. Available at: https://clinicaltrials.gov/ct2/show/ NCT02619942.30. Rujin Hopsital. Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC) In: ClinicalTrials. gov [Internet]. Bethesda (MD): NationalLibraryofMedicine (US), 2000. Available at: https://clinicaltrials.gov/ct2/ show/ NCT02942238.Rujin Hopsital. Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC) In: ClinicalTrials. gov [Internet]. Bethesda (MD): NationalLibraryofMedicine (US), 2000. Available at: https://clinicaltrials.gov/ct2/ show/ NCT02942238.31. Kernan W., Viscoli C., Makuch R. et al. Stratified randomization for clinical trials. J Clin Epidemiol 1999;52(1):19–26. PMID: 9973070.Kernan W., Viscoli C., Makuch R. et al. Stratified randomization for clinical trials. J Clin Epidemiol 1999;52(1):19–26. PMID: 9973070.32. Петрова Е.П., Каприн А.Д., Грецова О.В., Старинский В.В. Злокачестванные новообразования в России: обзор статистической информации за 1993–2013 гг. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2015. [Petrova E.P., Kaprin A.D., Gretsova O.V., Starinskiy V.V. Zlokacestvennoe neoplasms in Russia: an overview of statistical information for 1993–2013. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2015. (In Russ.)].Петрова Е.П., Каприн А.Д., Грецова О.В., Старинский В.В. Злокачестванные новообразования в России: обзор статистической информации за 1993–2013 гг. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2015. [Petrova E.P., Kaprin A.D., Gretsova O.V., Starinskiy V.V. Zlokacestvennoe neoplasms in Russia: an overview of statistical information for 1993–2013. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMIRTS” Minzdrava Rossii, 2015. (In Russ.)].33. Machin D., Campbell M., Tan S., Tan S. Sample size tables for clinical studies. Chinchester: Wiley-Blackwell, 2009.Machin D., Campbell M., Tan S., Tan S. Sample size tables for clinical studies. Chinchester: Wiley-Blackwell, 2009.34. Chow S.-C., Wang H., Shao J. Sample size calculations in clinical research. CRC Press, 2007.Chow S.-C., Wang H., Shao J. Sample size calculations in clinical research. CRC Press, 2007.35. Lachin J., Foulkes M. Evaluation of sample size and power for analysesLachin J., Foulkes M. Evaluation of sample size and power for analysesof survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986;42507–516. PMID: 3567285.